This study sets up a compound option approach for evaluating pharmaceutical R&D investment projects in the presence of technical and economic uncertainties. Technical uncertainty is modeled as a Poisson jump that allows for failure and thus abandonment of the drug development. Economic uncertainty is modeled as a standard diffusion process which incorporates both up-and downward shocks. Practical application of this method is emphasized through a case analysis. We show that both uncertainties have a positive impact on the R&D option value. Moreover, from the sensitivity analysis, we find that the sensitivity of the option with respect to economic uncertainty and market introduction cost decreases when technical uncertainty increases.

Additional Metadata
Keywords R&D, compound option, jump-diffusion process, pharmaceutical industry
Persistent URL dx.doi.org/10.1016/j.ejor.2011.01.055, hdl.handle.net/1765/23457
Citation
Pennings, H.P.G, & Sereno, L. (2011). Evaluating pharmaceutical R&D under technical and economic uncertainty. European Journal of Operational Research, 212(2), 374–385. doi:10.1016/j.ejor.2011.01.055